Anmari Christersson

Curriculum Vitae

2012-now          Inst. of Molecular Virology, University of Münster, Germany

2009-2014         diploma to Biomedical Analyst in Molecular Biology, DIW-MTA, Berlin

2010-2012         CVUA-MEL, Molecular Virology, Münster, Germany

2008-2009         histological laboratory, Clinic Hornheide, Münster, Germany

1999-2007         endocrinological and clinical diagnosis laboratory, Münster, Germany

1981-2000         serology, clinical virology and transfusion medicine at the Red Cross, Münster,

1979-1981         Graduated as a medical technical assistant, Helsinki, Finland

 

Projects

Provides experimental support to all projects of the lab.

 

Methods

Cell culture, virus infection, influenza, RSV, SARS-CoV-2, human Lung model, virus isolation, q-RT- PCR, western blotting, Elisa, hemagglutination tests, luciferase-assay, MTT-Assay, single cell isolation, transfection, co-Infection model with virus and bacteria, antibiotic resistance testing, Histology, Immunohistochemistry, cloning

 

Publications:

Aileen Faist, Sebastian Schloer, Angeles Mecate-Zambrano, Josua Janowski, André Schreiber, Yvonne Boergeling, Beate C.G Conrad, Sriram Kumar, Leonie Toebben, Klaus Schughart, Morris Baumgardt, Mirjana Kessler, Katja Hoenzke, Andreas Hocke, Marcel Trautmann, Wolfgang Hartmann, Hiroki Kato, Ursula Rescher, Anmari Christersson, Joachim Kuehn, Linda Brunotte 2019
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
Antiviral Research, Volume 209, January 2023, 105475
https://doi.org/10.1016/j.antiviral.2022.105475

Ferrando, V. A., Friedrich, M. E., Gandhi, S., Mellmann, A., Masemann, D., Christersson, A., … Ludwig, S. (2023). Cell-intrinsic genomic reassortment of pandemic H1N1 2009 and Eurasian avian-like swine influenza viruses results in potentially zoonotic variants. Emerging Microbes & Infections, 12(1). 
doi.org/10.1080/22221751.2023.2212809

Matos ADR, Wunderlich K, Schloer S, Schughart K, Geffers R, Seders M, Witt M, Christersson A, Wiewrodt R, Wiebe K, Barth P, Hocke A, Hippenstiel S, Honzke K, Dittmer U, Sutter K, Rescher U, Rodionycheva S, Matera N, Ludwig S, Brunotte L. 2019. 
Antiviral potential of human IFN-alpha subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities. 
Emerg Microbes Infect 8: 1763-76